Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

B Abrahamsen; Katrine Hass Rubin; P A Eiken; R Eastell

doi:10.1007/s00198-012-2184-6

Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

B Abrahamsen, Katrine Hass Rubin, P A Eiken, R Eastell

17 Citations (Scopus)

Abstract

Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.

Original language	English
Journal	Osteoporosis International
Volume	24
Issue number	1
Pages (from-to)	321-8
Number of pages	8
ISSN	0937-941X
DOIs	https://doi.org/10.1007/s00198-012-2184-6
Publication status	Published - 2013

Access to Document

10.1007/s00198-012-2184-6

Cite this

@article{2f726f6518ae44a68d97f22f37b9250a,

title = "Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study",

abstract = "Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.",

author = "B Abrahamsen and Rubin, \{Katrine Hass\} and Eiken, \{P A\} and R Eastell",

year = "2013",

doi = "10.1007/s00198-012-2184-6",

language = "English",

volume = "24",

pages = "321--8",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment

T2 - a National Prescription registry study

AU - Abrahamsen, B

AU - Rubin, Katrine Hass

AU - Eiken, P A

AU - Eastell, R

PY - 2013

Y1 - 2013

N2 - Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.

AB - Antiresorptive treatment reduces the risk of fractures, but most patients remain at elevated risk. We used health registers to identify predictors of new major osteoporotic fractures in patients adhering to alendronate. Risk factors showed a different pattern than in the general population and included dementia, ulcer disease, and Parkinson's disease.

UR - https://www.scopus.com/pages/publications/84872347532

U2 - 10.1007/s00198-012-2184-6

DO - 10.1007/s00198-012-2184-6

M3 - Journal article

C2 - 23070480

SN - 0937-941X

VL - 24

SP - 321

EP - 328

JO - Osteoporosis International

JF - Osteoporosis International

IS - 1

ER -

Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this